US › Healthcare

Vicarious Surgical Inc. (RBOT)

US · Healthcare · Medical Devices

$0.03+3.09%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-7.3M

EPS

$-1.65

EPS estimate

$-1.37

EPS came in at -1.65 against a street estimate of -1.37 — a miss of 20.4%.

Key statistics

Market cap

$206,809

Forward P/E

0.0

P/B

0.06

Book value

$0.50

EPS (TTM)

$-6.42

52-week high

$7.72

52-week low

$0.02

50-day MA

$0.08

200-day MA

$1.04

Beta

1.86

Analyst view

Analysts rate Vicarious Surgical Inc. a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $5.00.

Shareholding

Insiders

14.84%

Institutions

14.95%

Largest institutional holders

Fund	Stake
Aspex Management (HK) Ltd	1.22%
Forum Finance Group S.A.	0.05%
Rockefeller Capital Management L.P.	0.01%
Federation des caisses Desjardins du Quebec	0.00%
SignatureFD, LLC	0.00%
International Assets Investment Management, LLC	0.00%
Sound Income Strategies	0.00%
Connective Capital Management LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Vicarious Surgical Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.